News Release

Halifax, April 19, 2016 – Today, BioNova and Innovative Medicines Canada announced the signing of a memorandum of understanding between the organizations to foster collaboration in Canada’s life sciences communities between the pharmaceutical sector and life sciences organizations in Nova Scotia.

“This agreement will accelerate the development of pharmaceutical companies in Nova Scotia – supporting the local economy and giving Nova Scotian’s a voice for issues on a federal level,” said Scott Moffitt, Managing Director of BioNova. “We’re very pleased about this partnership and look forward to working closely with Innovative Medicines Canada.”

This memorandum of understanding will allow BioNova and Innovative Medicines Canada to offer a joint membership to life sciences companies and associated stakeholders in Canada in an effort to enhance networking opportunities and develop partnerships that will lead to the discovery of the next generation of life-saving therapies.

“Canada’s innovative pharmaceutical sector provides immense value to patients, to the healthcare system and to Canada’s economy as a whole,” said Russell Williams, President of Innovative Medicines Canada. “We look forward to promoting and stimulating this great, innovative work with BioNova to ensure that Nova Scotia’s life sciences economy can flourish in Canada to the benefit of all.”

About Innovative Medicines Canada

Innovative Medicines Canada is the national voice of Canada’s innovative pharmaceutical industry. We advocate for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. We support our members’ commitment to being valued partners in the Canadian healthcare system.

About BioNova

BioNova is Nova Scotia’s life sciences industry association and sector development organization. BioNova leads and supports its members as we build a successful, self-sustaining life sciences industry in Nova Scotia. By promoting the industry and its successes, building relationships both inside and outside the province and creating networking and educational opportunities BioNova aims to accelerate the commercialization success of Nova Scotia’s life sciences businesses and organizations.

– 30 –

 

For further information:

Sarah Douglas
Media Relations, Innovative Medicines Canada
Telephone: 613-883-7250
E-mail: sdouglas@imc-mnc.ca

 

Shana McRae
Marketing & Communications Officer, BioNova
Telephone: 902-421-5705 ext. 2
E-mail: smcrae@bionova.ca

 

2015 © Copyright - Bionova